rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    JSPR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Rodman & Renshaw reiterates Buy on Jasper Therapeutics stock
      Nov 17Investing.comJSPR
      Piper Sandler cuts Jasper Therapeutics stock price target to $44
      Nov 17Investing.comJSPR
      Jasper Therapeutics earnings missed by $7.79, revenue fell short of estimates
      Nov 16Investing.comJSPR
      Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants
      Nov 9Yahoo FinanceJSPR
      Jasper Therapeutics executes 1-for-30 reverse stock split
      Nov 4Investing.comJSPR
      Jasper Therapeutics Announces 1-for-30 Reverse Stock Split
      Nov 4Yahoo FinanceJSPR
      Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
      Oct 15Yahoo FinanceJSPR
      William Blair resumes Jasper Therapeutics stock with outperform rating
      Oct 14Investing.comJSPR
      Jasper Therapeutics launches tender offer for warrants
      Oct 7Investing.comJSPR
      Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
      Oct 7Yahoo FinanceJSPR
      Jasper Therapeutics Appoints Interim Finance and Governance Leaders

      Detailed price information for Jasper Therapeutics Inc. (JSPR-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailJSPR
      Jasper Therapeutics announces CFO resignation and interim appointments
      Sep 28Investing.comJSPR
      Jasper Therapeutics at H.C. Wainwright: cash and catalysts
      Sep 16Investing.comJSPR
      Jasper Therapeutics appoints two executives to key roles
      Sep 15Investing.comJSPR
      Jasper Therapeutics Announces Key Regulatory and Clinical Appointments

      Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory Affairs Shiguang Liu, M.D., Ph.D. appointed Vice President, Clinical Development REDWOOD CITY, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today announced the appointments of Lisa Pitt, Pharm.D., M.S.J. as Senior Vice President, Regulatory

      Sep 15Yahoo FinanceJSPR
      Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

      REDWOOD CITY, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today announced that management will participate at the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026 in New York, NY. H.C. Wainwright 28th Annual Global Investment ConferencePresentation Date/Time: Wednesda

      Sep 9Yahoo FinanceJSPR

      This is the newest page. Registered accounts read further back.